ANTI-CD20 MONOCLONAL ANTIBODIES IN TREATMENT OF HAEMOLYTIC ANEMIA IN A TEENAGE GIRL WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Haemolytic anemia occurs in 10% of the cases of systemic lupus erythematosus in children with hematological disturbances. High doses of glucocorticoids are used for the treatment of this condition. The second-line drugs in cases of refractory disease course are azathioprine, mycophenolate mofetil, c...
Saved in:
Main Authors: | R. V. Denisova (Author), E. I. Alexeeva (Author) |
---|---|
Format: | Book |
Published: |
"Paediatrician" Publishers LLC,
2012-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE)
by: Gabriella Moroni, et al.
Published: (2010) -
A rationally designed CD19 monoclonal antibody-triptolide conjugate for the treatment of systemic lupus erythematosus
by: Lai Wang, et al.
Published: (2024) -
Ofatumumab: a novel monoclonal anti-CD20 antibody
by: Thomas S Lin
Published: (2010) -
Anti-CD20 monoclonal antibodies: reviewing a revolution
by: J. M. L. Casan, et al.
Published: (2018) -
Systematic Review: Monoclonal Antibody-Induced Subacute Cutaneous Lupus Erythematosus
by: Chrissy Bolton, et al.
Published: (2020)